We combine expert analysis in use of our content and technology assets, proprietary analytical and visualization tools, and deep expertise in the pharmaceutical and life sciences business so you can benefit from tailored solutions that meet your unique business needs for faster, more informed decisions with higher confidence.
From discovery to launch and beyond, at every stage of the pipeline we can support you with the experts and intelligence to make the best decisions for your organization.
- Faster Hypothesis Testing Cycles, Improved Confidence, Human Disease Relevance of Insights
- Integration of clinical strategy and clinical operations to speed cycles times and improve success rates
- Better data collection approaches for approval and reimbursement claims
- Comprehensive, independent portfolio analysis and opportunity valuation without bias
- Customized approaches to drug repositioning for your organization
- Reduced cost of leveraging an advanced platform for performing research and analysis in major areas of interests to our customers
- Personalized medicine and translating scientific insights into patient therapies Find out how Thomson Reuters can help you find new paths to revenue from within your own portfolio.
- Acquire new disease understanding, therapeutic and business insights, and better decision-support capabilities
- Tailored solutions that meet your unique business needs
- Make faster, more informed decisions with higher confidence
Custom Reports and Analysis
Your questions answered by our team of expert analysts and researchers.
CMR International, a Thomson Reuters business, is the most established and reputable source of pharmaceutical industry metrics and trends analysis in the world.
Decision Support Tools
Cortellis for Decision Support is a series of easy to use, visual dashboards designed to reduce the time you spend compiling and analyzing intelligence, speeding time to approval and enhancing your competitive position from across the pipeline.
Drug Repositioning Services
Customized multi-disciplined approach to repositioning compounds, using our proprietary content and expertise we can evaluate opportunities using pathway analysis and other computational methods to connect data on drugs, disease pathways and proteins.
tranSMART Implementation Services
We offer a complete package of curation and ETL services to enable data processing, annotation, loading, management and visualization in tranSMART and integration with pathway analysis tools.
External Innovation Solutions
Our Professional Services team offer you a new way to identify, evaluate and access people and organizations working on new compounds, targets, technologies, and disease areas who will enhance your advantage over your competitors.
Strengthen your negotiating position through expert analysis on deal comparables. Use our expert analysts to run the optimal comparables by therapy areas, indications, drug classes, and specific companies. So you can set partnering strategies, supplement resources and close your deals with success.
Integrate, align, and deliver disparate internal and external competitive intelligence information so it can be shared across your enterprise consistently and securely. Thomson Reuters Cortellis™ for Information Integration enables secure hosting of your proprietary content, public information, and Thomson Reuters data on the Cortellis platform.
The MetaMiner program is a series of industry-academy partnerships on systems biology of common human diseases and stem cells, led by Thomson Reuters.
Rapid Insight Reports
Keep our expert team on stand-by to quickly identify key information from our industry leading databases, public domain sources, and other commercial sources to develop custom reports that offer you penetrating, objective insights, from detailed information about targets of interest to a complete overview of the clinical landscape.
Systems Biology Services
Professional analytical and knowledge management services for a variety of life science applications
Target Analytics and Intelligence
Our team of experts applies the most advanced analytical techniques in a variety of services on target identification, ranking and validation - backed by dozens of proprietary, best-in-class databases
Biopharmaceutical Market Research
Trusted insights for pharmaceutical, biotech, medical devices and healthcare –gain valuable insights, to develop successful products and market strategies.
Thomson Reuters has a dedicated professional services team that includes regulatory professionals, industry consultants and IT experts to support collaborations beyond our core content capabilities. Our services include customized regulatory newsletters, regulatory landscaping reports, and company internal documentation review and management.
White Papers & Case Studies
The economic power of orphan drugs
Measuring the Return from Pharma Innovation 2013
Knowledge-based drug repositioning to drive R&D productivity
Thomson Reuters Integrity℠ provides researchers with reliable, detailed information, from the perspective of a scientist, across multiple disciplines to support successful drug research and development.
The U.S. National Library of Medicine® (NLM®) premier bibliographic database, covering biomedicine and life sciences topics vital to biomedical practitioners, educators, and researchers, such as bioengineering, public health, and more.
Medical Device Daily™ is the news source of record for the high-tech medical technology industry and is relied on by thousands of industry insiders every business morning.